DRUG · Mapped RxNorm record
sunitinib
Normalized identity: sunitinibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
NCT00712504
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Solid Tumorsunresolved
Non Small Cell Lung Cancerunresolved
Interventions
sunitinibDRUG · verified · RxNorm: sunitinib
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00712504 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.